ArticleAmerican journal of nuclear medicine and molecular imaging2012

Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist.

Tessa Buckle et al.PubMed ↗Full text ↗

No numbers read from the abstract.